6-Bromo-2,3-Dioxoindolin Phenylacetamide Derivatives: Synthesis, Potent CDC25B, PTP1B Inhibitors and Anticancer Activity
作者:Shui-Lian Zhao、Zhou Peng、Xing-Hua Zhen、Yan Han、Hai-Ying Jiang、You-Le Qu、Li-Ping Guan
DOI:10.2174/1570180812666141219003209
日期:2015.6.6
A series of 6-bromo-2,3-dioxoindolin phenylacetamide derivatives was synthesized and
evaluated for inhibitory activity against CDC25B and PTP1B. Most of the synthesized compounds
showed potential inhibitory activities for CDC25B and PTP1B with compound 12 being the most potent
(IC50=3.87 µmol/L and 2.98 µmol/L, respectively). Compound 12 also exhibited higher cytotoxic activity
against three cancer cell lines (HeLa, A549 and HCT116). In addition, compound 12 delayed the potent tumor inhibitory activity
in a colo205 xenograft model in vivo.
合成了一系列6-溴-2,3-二氧吲哚苯乙酰胺衍生物,并评估了它们对CDC25B和PTP1B的抑制活性。大多数合成的化合物显示出对CDC25B和PTP1B具有潜在的抑制活性,其中化合物12的活性最强(IC50分别为3.87 µmol/L和2.98 µmol/L)。化合物12对三种癌细胞系(HeLa、A549和HCT116)也显示出较高的细胞毒活性。此外,化合物12在体内colo205异种移植模型中延迟了强效的肿瘤抑制活性。